Logo-bi
Original Research
Zeinab Karimi ORCID, Sahar Janfeshan, Elias Kargar Abarghouei, Seyedeh-Sara Hashemi* ORCID
BioImpacts. 2021;11(3): 219-226. doi: 10.34172/bi.2021.31
PMCID: PMC8314037     PMID: 34336610     Scopus ID: 85109076604    
Renal functional and structural disturbance induced by renal bilateral ischemia/reperfusion. However, administration of bone marrow stem cell (1.5×106 cells, i.p., per rat) improved renal function and appearance. Protective effect of BMSCs related to modulation of mRNA expression of TLR2 and TLR4.
Original Research
Mohammad A. Rafi ORCID, Paola Luzi, David A. Wenger* ORCID
Bioimpacts. 2020;10(2): 105-115. doi: 10.34172/bi.2020.13
PMCID: PMC7186542     PMID: 32363154     Scopus ID: 85090729388    
Krabbe disease (KD) is an autosomal recessive lysosomal disorder that imposes defective myelination in the peripheral and central nervous systems. Twitcher combining bone marrow transplantation with AAVrh10-mGALC can have a great extension of life in the murine model of KD.
Original Research
Sepideh Sheshpari ORCID, Mahnaz Shahnazi, Shahin Ahmadian, Mohammad Nouri, Mehran Mesgari Abbasi, Rahim Beheshti, Reza Rahbarghazi, Ali Honaramooz, Mahdi Mahdipour* ORCID
BioImpacts. 2022;12(4): 325-335. doi: 10.34172/bi.2021.23499
PMCID: PMC9376162     PMID: 35975202     Scopus ID: 85138756745    
The administration of c-Kit+ cells can modulate angiogenesis and pathological changes, leading to the rejuvenation of ovarian function of a rat model of premature menopause.
Original Research
Mohammad A Rafi* ORCID, Paola Luzi, David A Wenger ORCID
BioImpacts. 2021;11(2): 135-146. doi: 10.34172/bi.2021.21
PMCID: PMC8022232     PMID: 33842284     Scopus ID: 85106877684    
Our results demonstrate that, it may be possible to treat human KD patients with high dose AAVrh10 without blood stem cell transplantation which would eliminate the side effects of HSCT.
Mini Review
Mohammad A. Rafi* ORCID
Bioimpacts. 2022;12(1): 3-7. doi: 10.34172/bi.2021.23931
PMCID: PMC8783082     PMID: 35087711     Scopus ID: 85127157009    
Cutting viral dose in half or using BM cells from heterozygote mice in a combination of BMT and gene therapy treatments result in a similar reduction in lifespan of the treated mice.
Original Article
Nahideh Nazdikbin Yamchi ORCID, Farhad Amjadi, Rahim Beheshti, Mehdi Hassanpour, Reza Shirazi, Amin Tamadon ORCID, Reza Rahbarghazi ORCID, Mahdi Mahdipour* ORCID
Bioimpacts. 2023;13(6): 495-504. doi: 10.34172/bi.2023.27781
PMCID: PMC10676523     PMID: 38022384     Scopus ID: 85172811127    


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge